Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender (Q56944785)
Jump to navigation
Jump to search
article
Language | Label | Description | Also known as |
---|---|---|---|
English | Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender |
article |
Statements
Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the Prevention of Ischemic Complications. Evaluation in Percutaneous Transluminal Coronary Angioplasty to Improve Long-Term Outcome with Abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stent (English)
R Califf
L Cho
C Balog
J M Foody
J E Booth
C Cabot
N S Kleiman
1 August 2000